PREMIUM WILKES NSG 552 ADVANCED
PSYCHOPHARMACOLOGY EXAM 1 PREP
PACK REAL SCENARIOS, ANSWERS, &
EXPERT RATIONALES
Master your advanced psychopharmacology curriculum with this ultimate,
high-yield compilation of comprehensive practice questions and scenario-
based clinical assessments. Each item features a professionally tailored
multiple-choice setup accompanied by exact italicized answers and deeply
verified, bold-italic rationales mapping complex pharmacodynamics and
pharmacokinetics. Perfect for accelerated study, this premium resource
guarantees absolute mastery over high-stakes exams, board preparation,
and complex clinical decision-making models.
Question 1: Neurobiology of Schizophrenia Symptoms
A 29-year-old female presents with severe auditory
hallucinations and persecutory delusions. Concurrently,
she exhibits profound flat affect, avolition, and social
withdrawal. Which statement accurately maps these
symptoms to their respective dopaminergic pathways?
A) Both positive and negative symptoms are driven by
mesolimbic hyperactivity.
B) Positive symptoms result from mesocortical
hypoactivity; negative symptoms result from mesolimbic
hyperactivity.
C) Positive symptoms result from mesolimbic
hyperactivity; negative symptoms result from mesocortical
hypoactivity.
D) Negative symptoms result from nigrostriatal
degeneration; positive symptoms result from
,tuberoinfundibular hyperactivity.
Rationale: The mesolimbic dopamine pathway projects
from the ventral tegmental area (VTA) to the nucleus
accumbens; hyperactivity here drives positive
symptoms (hallucinations/delusions). Conversely, the
mesocortical dopamine pathway projects from the
VTA to the prefrontal cortex; hypoactivity here drives
the negative, cognitive, and affective symptoms of
schizophrenia. The nigrostriatal pathway regulates
motor function, and the tuberoinfundibular pathway
regulates prolactin secretion.
Question 2: Antidepressant Washout Periods
A patient with treatment-resistant depression is being
cross-tapered from Fluoxetine to the Monoamine Oxidase
Inhibitor (MAOI) Phenelzine. To prevent serotonin
syndrome, what is the mandatory minimum washout
period required?
A) 14 days
B) 35 days
C) 7 days
D) 21 days
Rationale: While most Selective Serotonin Reuptake
Inhibitors (SSRIs) require a 14-day washout period
before initiating an MAOI, Fluoxetine has an
exceptionally prolonged half-life (4 to 6 days) and an
active metabolite, norfluoxetine, with a half-life of up
to 16 days. Consequently, a minimum of 5 weeks (35
days) is strictly mandatory to clear all serotonergic
,compounds and avoid fatal serotonin syndrome or
hypertensive crises.
Question 3: Mood Stabilizer Titration Safety
A PMHNP is initiating Lamotrigine for a patient diagnosed
with Bipolar I disorder, current episode depressed. What is
the standard, safest initial dosing regimen to mitigate the
risk of Stevens-Johnson Syndrome (SJS)?
A) 25 mg daily for weeks 1 and 2, then 50 mg daily for
weeks 3 and 4
B) 50 mg daily for week 1, then 100 mg daily for week 2
C) 100 mg daily for 2 weeks, then titration to 200 mg daily
D) 25 mg twice daily for week 1, then 50 mg twice daily for
week 2
Rationale: Stevens-Johnson Syndrome (SJS) and
Toxic Epidermal Necrolysis (TEN) are rare but life-
threatening immune-mediated dermatological
reactions linked to Lamotrigine. The risk is directly
correlated with rapid initial dosing and fast titration.
The standard manufacturer-recommended titration
schedule demands starting at 25 mg daily for the first
14 days, followed by 50 mg daily for days 15–28,
before further escalating.
Question 4: Extrapyramidal Symptoms (EPS)
Mechanism
Two hours after receiving an intramuscular injection of
Haloperidol for acute psychosis, a 22-year-old male
develops a severe, painful twisting of the neck (torticollis)
, and upward deviation of the eyes. This acute dystonic
reaction is caused by:
A) Under-activation of central muscarinic acetylcholine
receptors.
B) Acute, profound blockade of dopamine D2 receptors in
the nigrostriatal pathway.
C) Hyperactivity of the mesolimbic dopamine tract.
D) Upregulation of 5-HT2A serotonin receptors in the
basal ganglia.
Rationale: Acute dystonia is an extrapyramidal
symptom (EPS) precipitated by high-potency first-
generation antipsychotics. It is caused by an abrupt,
intense blockade of postsynaptic dopamine D2
receptors in the nigrostriatal pathway, which creates a
relative excess of cholinergic (acetylcholine) activity
in the striatum, triggering involuntary muscle spasms.
Question 5: Pharmacokinetics and First-Pass
Metabolism
A patient is prescribed Asenapine for the treatment of
schizophrenia. The clinical instructions emphasize that the
tablet must be dissolved completely under the tongue, and
the patient must not eat or drink for 10 minutes. What is
the pharmacokinetic rationale for this?
A) Sublingual absorption slows down the drug's entry into
the central nervous system to reduce sedation.
B) The drug undergoes extensive hepatic first-pass
metabolism if swallowed, resulting in near-zero
bioavailability.
PSYCHOPHARMACOLOGY EXAM 1 PREP
PACK REAL SCENARIOS, ANSWERS, &
EXPERT RATIONALES
Master your advanced psychopharmacology curriculum with this ultimate,
high-yield compilation of comprehensive practice questions and scenario-
based clinical assessments. Each item features a professionally tailored
multiple-choice setup accompanied by exact italicized answers and deeply
verified, bold-italic rationales mapping complex pharmacodynamics and
pharmacokinetics. Perfect for accelerated study, this premium resource
guarantees absolute mastery over high-stakes exams, board preparation,
and complex clinical decision-making models.
Question 1: Neurobiology of Schizophrenia Symptoms
A 29-year-old female presents with severe auditory
hallucinations and persecutory delusions. Concurrently,
she exhibits profound flat affect, avolition, and social
withdrawal. Which statement accurately maps these
symptoms to their respective dopaminergic pathways?
A) Both positive and negative symptoms are driven by
mesolimbic hyperactivity.
B) Positive symptoms result from mesocortical
hypoactivity; negative symptoms result from mesolimbic
hyperactivity.
C) Positive symptoms result from mesolimbic
hyperactivity; negative symptoms result from mesocortical
hypoactivity.
D) Negative symptoms result from nigrostriatal
degeneration; positive symptoms result from
,tuberoinfundibular hyperactivity.
Rationale: The mesolimbic dopamine pathway projects
from the ventral tegmental area (VTA) to the nucleus
accumbens; hyperactivity here drives positive
symptoms (hallucinations/delusions). Conversely, the
mesocortical dopamine pathway projects from the
VTA to the prefrontal cortex; hypoactivity here drives
the negative, cognitive, and affective symptoms of
schizophrenia. The nigrostriatal pathway regulates
motor function, and the tuberoinfundibular pathway
regulates prolactin secretion.
Question 2: Antidepressant Washout Periods
A patient with treatment-resistant depression is being
cross-tapered from Fluoxetine to the Monoamine Oxidase
Inhibitor (MAOI) Phenelzine. To prevent serotonin
syndrome, what is the mandatory minimum washout
period required?
A) 14 days
B) 35 days
C) 7 days
D) 21 days
Rationale: While most Selective Serotonin Reuptake
Inhibitors (SSRIs) require a 14-day washout period
before initiating an MAOI, Fluoxetine has an
exceptionally prolonged half-life (4 to 6 days) and an
active metabolite, norfluoxetine, with a half-life of up
to 16 days. Consequently, a minimum of 5 weeks (35
days) is strictly mandatory to clear all serotonergic
,compounds and avoid fatal serotonin syndrome or
hypertensive crises.
Question 3: Mood Stabilizer Titration Safety
A PMHNP is initiating Lamotrigine for a patient diagnosed
with Bipolar I disorder, current episode depressed. What is
the standard, safest initial dosing regimen to mitigate the
risk of Stevens-Johnson Syndrome (SJS)?
A) 25 mg daily for weeks 1 and 2, then 50 mg daily for
weeks 3 and 4
B) 50 mg daily for week 1, then 100 mg daily for week 2
C) 100 mg daily for 2 weeks, then titration to 200 mg daily
D) 25 mg twice daily for week 1, then 50 mg twice daily for
week 2
Rationale: Stevens-Johnson Syndrome (SJS) and
Toxic Epidermal Necrolysis (TEN) are rare but life-
threatening immune-mediated dermatological
reactions linked to Lamotrigine. The risk is directly
correlated with rapid initial dosing and fast titration.
The standard manufacturer-recommended titration
schedule demands starting at 25 mg daily for the first
14 days, followed by 50 mg daily for days 15–28,
before further escalating.
Question 4: Extrapyramidal Symptoms (EPS)
Mechanism
Two hours after receiving an intramuscular injection of
Haloperidol for acute psychosis, a 22-year-old male
develops a severe, painful twisting of the neck (torticollis)
, and upward deviation of the eyes. This acute dystonic
reaction is caused by:
A) Under-activation of central muscarinic acetylcholine
receptors.
B) Acute, profound blockade of dopamine D2 receptors in
the nigrostriatal pathway.
C) Hyperactivity of the mesolimbic dopamine tract.
D) Upregulation of 5-HT2A serotonin receptors in the
basal ganglia.
Rationale: Acute dystonia is an extrapyramidal
symptom (EPS) precipitated by high-potency first-
generation antipsychotics. It is caused by an abrupt,
intense blockade of postsynaptic dopamine D2
receptors in the nigrostriatal pathway, which creates a
relative excess of cholinergic (acetylcholine) activity
in the striatum, triggering involuntary muscle spasms.
Question 5: Pharmacokinetics and First-Pass
Metabolism
A patient is prescribed Asenapine for the treatment of
schizophrenia. The clinical instructions emphasize that the
tablet must be dissolved completely under the tongue, and
the patient must not eat or drink for 10 minutes. What is
the pharmacokinetic rationale for this?
A) Sublingual absorption slows down the drug's entry into
the central nervous system to reduce sedation.
B) The drug undergoes extensive hepatic first-pass
metabolism if swallowed, resulting in near-zero
bioavailability.
